When it comes to diabetic eye diseases, there are a multitude of potential treatments—but perhaps the “easiest” one for patients is to ensure their A1C levels are under control.
When it comes to diabetic eye diseases, there are a multitude of potential treatments—but perhaps the “easiest” one for patients is to ensure their A1C levels are under control.1
For those with type 1 diabetes, fasting glucose levels may be as much as 3 times the normal range (70-100 mg/dL), whereas those with type 2 diabetes often have high-fasting glucose levels of 150 mg/dL or higher.
According to Versant Health, diabetes affects more than 30 million Americans (about 9.4% of the population). Of those, nearly 30% (or 10 million people), have diabetic retinopathy (DR), a potentially blinding disease that costs Americans more than $500 million every year.
In its white paper, "The health and financial costs of diabetic retinopathy," Mark Ruchman, MD, Chief Medical Officer at Versant Health and Elizabeth Klunk, RN, senior vice president of Versant Health, note that 20% of people first learn they are diabetic through the results of an eye exam.
1. American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern: Diabetic Retinopathy. San Francisco, CA: AAO, 2016.
2. Aiello LP, Group DER. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37(1):17-23.
3. Murchison AP, Hark L, Pizzi LT, et al. Non-adherence to eye care in people with diabetes. BMJ Open Diabetes Res Care. 2017;5(1):e000333.